The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...
DELRAY BEACH, Fla, Dec. 15, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the Pharmaceutical Manufacturing Execution ...
The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste.
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that a leading Cell and Gene Therapy (CGT) manufacturer has ...
The pharmaceutical isolator market offers strategic growth via advanced contamination control technologies addressing sterility and compliance pressures. Key opportunities include scalable and ...
The CNPV program significantly reduces drug review times, necessitating operational shifts for sponsors to meet compressed timelines. Sponsors must execute market access, pricing, and post-approval ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Towa Pharmaceutical ...
The project represents a strategic step towards localising the production of vaccines and biological medicines ...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announces its acquisition of the clinical trial materials ...
TOMI Environmental Solutions, Inc.- ("TOMI") (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback